Epicardial fat and atrial fibrillation: Current evidence, potential mechanisms, clinical implications, and future directions

Christopher X. Wong, Anand N. Ganesan, Joseph B. Selvanayagam

Research output: Contribution to journalReview article

60 Citations (Scopus)

Abstract

Obesity is increasingly recognized as a major modifiable determinant of atrial fibrillation (AF). Although body mass index and other clinical measures are useful indications of general adiposity, much recent interest has focused on epicardial fat, a distinct adipose tissue depot that can be readily assessed using non-invasive imaging techniques. A growing body of data from epidemiological and clinical studies has demonstrated that epicardial fat is consistently associated with the presence, severity, and recurrence of AF across a range of clinical settings. Evidence from basic science and translational studies has also suggested that arrhythmogenic mechanisms may involve adipocyte infiltration, pro-fibrotic, and pro-inflammatory paracrine effects, oxidative stress, and other pathways. Despite these advances, however, significant uncertainty exists and many questions remain unanswered. In this article, we review our present understanding of epicardial fat, including its classification and quantification, existing evidence implicating its role in AF, potential mechanisms, implications for clinicians, and future directions for research. Published on behalf of the European Society of Cardiology. All rights reserved.

LanguageEnglish
Pages1294-1302
Number of pages9
JournalEuropean Heart Journal
Volume38
Issue number17
DOIs
Publication statusPublished - 1 May 2017

Keywords

  • Adiposity
  • Atrial fibrillation
  • Body mass index
  • Cardiac magnetic resonance imaging
  • Computed tomography
  • Echocardiography
  • Epicardial fat
  • Obesity
  • Pericardial fat
  • Visceral adipose tissue
  • Waist circumference
  • Waist-to-hip ratio

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{ef0cefc69b7649c99a54ef5ed67ede43,
title = "Epicardial fat and atrial fibrillation: Current evidence, potential mechanisms, clinical implications, and future directions",
abstract = "Obesity is increasingly recognized as a major modifiable determinant of atrial fibrillation (AF). Although body mass index and other clinical measures are useful indications of general adiposity, much recent interest has focused on epicardial fat, a distinct adipose tissue depot that can be readily assessed using non-invasive imaging techniques. A growing body of data from epidemiological and clinical studies has demonstrated that epicardial fat is consistently associated with the presence, severity, and recurrence of AF across a range of clinical settings. Evidence from basic science and translational studies has also suggested that arrhythmogenic mechanisms may involve adipocyte infiltration, pro-fibrotic, and pro-inflammatory paracrine effects, oxidative stress, and other pathways. Despite these advances, however, significant uncertainty exists and many questions remain unanswered. In this article, we review our present understanding of epicardial fat, including its classification and quantification, existing evidence implicating its role in AF, potential mechanisms, implications for clinicians, and future directions for research. Published on behalf of the European Society of Cardiology. All rights reserved.",
keywords = "Adiposity, Atrial fibrillation, Body mass index, Cardiac magnetic resonance imaging, Computed tomography, Echocardiography, Epicardial fat, Obesity, Pericardial fat, Visceral adipose tissue, Waist circumference, Waist-to-hip ratio",
author = "Wong, {Christopher X.} and Ganesan, {Anand N.} and Selvanayagam, {Joseph B.}",
year = "2017",
month = "5",
day = "1",
doi = "10.1093/eurheartj/ehw045",
language = "English",
volume = "38",
pages = "1294--1302",
journal = "European heart journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "17",

}

Epicardial fat and atrial fibrillation : Current evidence, potential mechanisms, clinical implications, and future directions. / Wong, Christopher X.; Ganesan, Anand N.; Selvanayagam, Joseph B.

In: European Heart Journal, Vol. 38, No. 17, 01.05.2017, p. 1294-1302.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Epicardial fat and atrial fibrillation

T2 - European heart journal

AU - Wong, Christopher X.

AU - Ganesan, Anand N.

AU - Selvanayagam, Joseph B.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Obesity is increasingly recognized as a major modifiable determinant of atrial fibrillation (AF). Although body mass index and other clinical measures are useful indications of general adiposity, much recent interest has focused on epicardial fat, a distinct adipose tissue depot that can be readily assessed using non-invasive imaging techniques. A growing body of data from epidemiological and clinical studies has demonstrated that epicardial fat is consistently associated with the presence, severity, and recurrence of AF across a range of clinical settings. Evidence from basic science and translational studies has also suggested that arrhythmogenic mechanisms may involve adipocyte infiltration, pro-fibrotic, and pro-inflammatory paracrine effects, oxidative stress, and other pathways. Despite these advances, however, significant uncertainty exists and many questions remain unanswered. In this article, we review our present understanding of epicardial fat, including its classification and quantification, existing evidence implicating its role in AF, potential mechanisms, implications for clinicians, and future directions for research. Published on behalf of the European Society of Cardiology. All rights reserved.

AB - Obesity is increasingly recognized as a major modifiable determinant of atrial fibrillation (AF). Although body mass index and other clinical measures are useful indications of general adiposity, much recent interest has focused on epicardial fat, a distinct adipose tissue depot that can be readily assessed using non-invasive imaging techniques. A growing body of data from epidemiological and clinical studies has demonstrated that epicardial fat is consistently associated with the presence, severity, and recurrence of AF across a range of clinical settings. Evidence from basic science and translational studies has also suggested that arrhythmogenic mechanisms may involve adipocyte infiltration, pro-fibrotic, and pro-inflammatory paracrine effects, oxidative stress, and other pathways. Despite these advances, however, significant uncertainty exists and many questions remain unanswered. In this article, we review our present understanding of epicardial fat, including its classification and quantification, existing evidence implicating its role in AF, potential mechanisms, implications for clinicians, and future directions for research. Published on behalf of the European Society of Cardiology. All rights reserved.

KW - Adiposity

KW - Atrial fibrillation

KW - Body mass index

KW - Cardiac magnetic resonance imaging

KW - Computed tomography

KW - Echocardiography

KW - Epicardial fat

KW - Obesity

KW - Pericardial fat

KW - Visceral adipose tissue

KW - Waist circumference

KW - Waist-to-hip ratio

UR - http://www.scopus.com/inward/record.url?scp=85019475579&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehw045

DO - 10.1093/eurheartj/ehw045

M3 - Review article

VL - 38

SP - 1294

EP - 1302

JO - European heart journal

JF - European heart journal

SN - 0195-668X

IS - 17

ER -